[Evaluation of drugs: efficacy, applicability, effectiveness and efficiency]
- PMID: 9623142
[Evaluation of drugs: efficacy, applicability, effectiveness and efficiency]
Abstract
In view of rising costs of drugs and the limited budget, government, institutes, researchers, prescribers, pharmacists and pharmaceutical industries should have a standardized assessment system at their disposal on which to base their pharmacotherapeutic policy. Evaluation can be achieved in four successive steps, taking into account both therapeutical and financial aspects. The first two steps, determining efficacy and applicability, represent the current system of evaluating drugs before allowance to the market. Steps 3 and 4 describe the ways in which effectiveness and efficiency can be involved in the evaluation by means of (cost) effectiveness analysis. Achieving optimal results from this stepwise approach requires speedy acceptance of the currently available guidelines for effective and efficient research.
Similar articles
-
[Pharmaco-economic evaluations of new drugs: potential key to a more efficient allocation of the health care budget].Ned Tijdschr Geneeskd. 2002 Jun 8;146(23):1068-71. Ned Tijdschr Geneeskd. 2002. PMID: 12085554 Dutch.
-
Procedures and methods of benefit assessments for medicines in Germany.Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5. Eur J Health Econ. 2008. PMID: 18987905
-
[More care for a limited budget; a case for a better use of the efficiency criteria].Ned Tijdschr Geneeskd. 2002 Nov 23;146(47):2254-8. Ned Tijdschr Geneeskd. 2002. PMID: 12481524 Dutch.
-
Generalised cost-effectiveness analysis: an aid to decision making in health.Appl Health Econ Health Policy. 2002;1(2):89-95. Appl Health Econ Health Policy. 2002. PMID: 14619255 Review.
-
The conceptual model for nursing and health policy revisited.Policy Polit Nurs Pract. 2005 Nov;6(4):319-26. doi: 10.1177/1527154405283304. Policy Polit Nurs Pract. 2005. PMID: 16443986 Review.